Login / Signup

The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials.

Nandu ThalangeLarry DeebGeorgeanna KlingensmithDenise R FrancoLars BardtrumDeniz TutkunkardasThomas Danne
Published in: Pediatric diabetes (2019)
These trials, the first to systematically collect data on ketosis in pediatric patients with T1D, demonstrate the potential of degludec/IDegAsp to reduce rates of metabolic decompensation, compared with IDet.
Keyphrases
  • type diabetes
  • electronic health record
  • big data
  • glycemic control
  • machine learning
  • young adults
  • human health
  • combination therapy
  • risk assessment
  • insulin resistance
  • weight loss